A Study of Knowledge about Deferasirox and Behavior of Taking Deferasirox in Patients with β-Thalassemia Major

碩士 === 國立臺灣大學 === 護理學研究所 === 100 === Background: Patients with β-thalassemia major require life-long periodic blood transfusions for treatment due to abnormal hematopoietic function. Among all the side effects derived from blood transfusion, organ failure caused by hemochromatosis is the most common...

Full description

Bibliographic Details
Main Authors: Pei-Yi Mei, 梅珮儀
Other Authors: 李雅玲
Format: Others
Language:zh-TW
Published: 2012
Online Access:http://ndltd.ncl.edu.tw/handle/27228442679579964362